$0.32
7.40% day before yesterday
Nasdaq, Oct 17, 10:16 pm CET
ISIN
US1897631057
Symbol
CODX

Co-Diagnostics, Inc. Stock price

$0.32
-0.09 22.27% 1M
-0.02 6.68% 6M
-0.43 56.77% YTD
-0.93 74.06% 1Y
-2.77 89.51% 3Y
-13.30 97.62% 5Y
-5.49 94.42% 10Y
-5.49 94.42% 20Y
Nasdaq, Closing price Fri, Oct 17 2025
-0.03 7.40%

Key metrics

Basic
Market capitalization
$15.6m
Enterprise Value
$2.3m
Net debt
positive
Cash
$13.4m
Shares outstanding
36.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
15.6 | 29.8
EV/Sales
2.3 | 4.3
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
84.9%
Return on Equity
-69.3%
ROCE
-90.6%
ROIC
-124.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.0m | $523.3k
EBITDA
$-37.5m | -
EBIT
$-38.8m | $-31.4m
Net Income
$-36.0m | $-27.9m
Free Cash Flow
$-33.2m
Growth (TTM | estimate)
Revenue
-89.1% | -86.7%
EBITDA
-0.1% | -
EBIT
-0.1% | 21.8%
Net Income
4.2% | 26.0%
Free Cash Flow
-26.5%
Margin (TTM | estimate)
Gross
39.6%
EBITDA
-3,733.3% | -
EBIT
-3,860.9%
Net
-3,585.8% | -5,324.7%
Free Cash Flow
-3,311.2%
More
EPS
$-1.1
FCF per Share
$-0.9
Short interest
1.0%
Employees
132
Rev per Employee
$30.0k
Show more

Is Co-Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Co-Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Co-Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1 1
89% 89%
100%
- Direct Costs 0.61 0.61
83% 83%
61%
0.40 0.40
93% 93%
40%
- Selling and Administrative Expenses 19 19
5% 5%
1,862%
- Research and Development Expense 19 19
17% 17%
1,924%
-37 -37
0% 0%
-3,747%
- Depreciation and Amortization 1.28 1.28
0% 0%
128%
EBIT (Operating Income) EBIT -39 -39
0% 0%
-3,875%
Net Profit -36 -36
4% 4%
-3,599%

In millions USD.

Don't miss a Thing! We will send you all news about Co-Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Co-Diagnostics, Inc. Stock News

Neutral
PRNewsWire
3 days ago
New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagnostics SALT LAKE CITY , Oct. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of m...
Neutral
PRNewsWire
6 days ago
SALT LAKE CITY , Oct. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today its participation in the upcoming 2025 Maxim Growth Summit, taking place October 22-23 at The Hard Rock Hotel NYC. The prestigious event brings together i...
Neutral
PRNewsWire
19 days ago
SALT LAKE CITY , Sept. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in a webcast presentation and hosting one-on-one meetings with institutional investors at the Lytham Partners Fall 2025 Inv...
More Co-Diagnostics, Inc. News

Company Profile

Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Dwight Egan
Employees 132
Founded 2013
Website codiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today